Doctors Question State Lawsuits Over Pelvic Mesh Products
THURSDAY, Jan. 10, 2019 -- State lawsuits over pelvic mesh products could scare women away from the products or even get them removed from the market, a group of doctors say.
The products, used to treat pelvic floor disorders and incontinence, are the subjects of lawsuits by Washington, California, Kentucky, and Mississippi. The states claim that Johnson & Johnson did not fully disclose safety risks, the Associated Press reported. But some doctors who specialize in female pelvic medicine oppose the lawsuits. In Washington, 63 surgeons signed a letter to state Attorney General Bob Ferguson saying the lawsuit is misguided.
"We have served on national and regional medical societies in women's health," wrote Jeffrey Clemons, M.D., a pelvic reconstructive surgeon in Tacoma, Washington. "It is astonishing to us that the AG is proceeding with this lawsuit without first availing themselves of the significant experience and expertise of this group." Doctors in California are drafting a similar letter to Attorney General Xavier Becerra. The president of the American Urogynecologic Society, which has 1,900 members, has issued a statement expressing similar concerns about the lawsuits, the AP reported.
Pelvic mesh products became available in the United States in the late 1990s and have been used to treat urinary incontinence and pelvic organ prolapse. But in 2008 and 2011, the Food and Drug Administration issued warnings about serious complications with pelvic mesh products used to treat pelvic organ prolapse, including permanent incontinence, severe discomfort, and an inability to have sex. Most of the pelvic mesh products for organ prolapse have been taken off the market in the United States, the AP reported. Johnson & Johnson and other companies face liability claims from tens of thousands of women over the products.
© 2020 HealthDay. All rights reserved.
Posted: January 2019
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
- Monthly Update Archive
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.